OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS)
NCT07650838
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma (STS)
Interventions
DRUG:
OVV-01，AK112
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences